Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0002047607-26-000004

Chief Strategy Officer acquired 34,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Riley Jennifer · Chief Strategy Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-21 Grant or award : show line 1 in the form +34,200 36,855 D
Loading xslF345X06/form4-05262026_040508.xml…